N. Fettig

Measurement of input functions in rodents: challenges and solutions.

P. Herrero, Joonyoung Kim, T. Sharp, 2005, Nuclear medicine and biology.

An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis

K. Korach, N. Fettig, S. Devanathan, 2014, PloS one.

Cardiomyopathy Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic

Xianlin Han, J. Nerbonne, T. Sharp, 2005 .

Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy

Xianlin Han, J. Nerbonne, T. Sharp, 2005, Circulation research.

Sexual dimorphism in myocardial acylcarnitine and triglyceride metabolism

R. Gropler, N. Fettig, S. Devanathan, 2016, Biology of Sex Differences.

Preclinical PERCIST and 25% of SUVmax Threshold: Precision Imaging of Response to Therapy in Co-clinical 18F-FDG PET Imaging of Triple-Negative Breast Cancer Patient–Derived Tumor Xenografts

R. Wahl, Jingqin Luo, Shunqiang Li, 2019, The Journal of Nuclear Medicine.

INJECTABLE HYDROGELS FOR LOCALIZED CHEMO- AND RADIO-THERAPY IN BRAIN TUMORS

S. Goddu, C. Tsien, N. Fettig, 2018 .

Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.

T. Sharp, Jason S. Lewis, M. Welch, 2008, Nuclear medicine and biology.

Time Course of Alterations in Myocardial Glucose Utilization in the Zucker Diabetic Fatty Rat with Correlation to Gene Expression of Glucose Transporters: A Small-Animal PET Investigation

Yi Su, P. Herrero, T. Sharp, 2008, Journal of Nuclear Medicine.

Transgenic Expression of FATP1 in the Heart Causes Lipotoxic Cardiomyopathy

Xianlin Han, J. Nerbonne, T. Sharp, 2004 .

Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.

N. Fettig, R. Rossin, M. Shokeen, 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Genomic and Metabolic Disposition of Non-Obese Type 2 Diabetic Rats to Increased Myocardial Fatty Acid Metabolism

R. Gropler, N. Fettig, S. Devanathan, 2013, PloS one.

Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input.

Sudheer D. Rani, N. Fettig, K. Shoghi, 2013, Nuclear medicine and biology.

Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors.

S. Goddu, C. Tsien, N. Fettig, 2017, Journal of pharmaceutical sciences.

Longitudinal Noninvasive Imaging of Progesterone Receptor as a Predictive Biomarker of Tumor Responsiveness to Estrogen Deprivation Therapy

John A. Katzenellenbogen, Farrokh Dehdashti, C. Dence, 2014, Clinical Cancer Research.

Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging.

Ananth Annapragada, Lohitash Karumbaiah, Cristian T Badea, 2011, Academic radiology.

In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PET

S. Achilefu, J. Dipersio, N. Fettig, 2021, EJNMMI Research.

Small-Animal PET of Steroid Hormone Receptors Predicts Tumor Response to Endocrine Therapy Using a Preclinical Model of Breast Cancer

C. Dence, T. Sharp, M. Welch, 2012, The Journal of Nuclear Medicine.